Federal Judge Blocks Sun Pharma’s U.S. Launch of Hair Loss Drug in Patent Dispute with Incyte

In the latest development regarding patent litigation in the pharmaceutical industry, a federal judge in New Jersey has issued an order preventing Sun Pharmaceutical Industries from launching its hair loss treatment in the United States. This decision represents a significant win for Incyte Corporation, which had filed a patent infringement lawsuit against the Indian pharmaceutical giant. Detailed information about the case is available through Law360.